Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1994;2(1):3–9. doi: 10.1155/S1064744994000311

Induction of Tumor Necrosis Factor and Interleukin-6 mRNA in Human Cytotrophoblast Cells Exposed to Lipopolysaccharide

Bernard Gonik 1,3,✉, Jacob Rachmilewitz 2, Avraham Hochberg 2, Ran Goshen 2, Nathan de-Groot 2
PMCID: PMC2364360  PMID: 18475358

Abstract

Objective: The cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) have previously been identified in placental tissue and are known to be mediators of infection-associated induction of the host immune system. This study was undertaken to better characterize the in vitro regulation of these cytokines in cytotrophoblast cells when challenged with the bacterial product lipopolysaccharide (LPS).

Methods: Term placentas were freshly collected, digested with trypsin/DNase, and subjected to Percoll gradient centrifugation to isolate cytotrophoblasts. Either immediately or after overnight incubation, LPS (1 μg/ml) or media alone was added to the cell cultures for 0, 1, 2, 4, 8, 24, 48, and 72 h. Total cellular RNA was isolated by the guanidinium thiocyanate/cesium chloride methodology. RNA samples were run on 1% agarose-formaldehyde gels and subsequently transferred to nylon filters. Blots were hybridized with the appropriate P32-radiolabeled probe.

Results: In non-LPS-treated cells, minimal amounts of TNF mRNA could be detected at zero time, or throughout the incubation periods. Conversely, LPS exposure resulted in detectable signal starting at 1 h and peaking at 2 h after the addition of LPS. Overnight incubation gave stronger TNF signals in the LPS stimulated cells, although the kinetics of this response remained similar to zero time exposure. IL-6 was likewise minimally expressed at zero time, although non-stimulated cell cultures demonstrated progressive increases in mRNA expression which was maximal at 16 h after plating. LPS further augmented the transcription of IL-6 mRNA, with peak signals seen at 4 h after LPS stimulation. Again, overnight incubation of the cytotrophoblasts increased baseline and LPS-induced IL-6 mRNA responses. Long-term constant exposure of cells to LPS did not demonstrate any evidence of prolonged signaling. LPS did not alter mRNA expression of the placental gene H19 or the oncogene FOS.

Conclusions: These data demonstrate the induction of TNF and IL-6 mRNA in cytotrophoblast cells with LPS. These transcriptional events are kinetically distinct and short term in nature. Overnight incubation accentuates the TNF and IL-6 mRNA signal and allows for an augmented response to LPS.

Full Text

The Full Text of this article is available as a PDF (454.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Casey M. L., Cox S. M., Beutler B., Milewich L., MacDonald P. C. Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J Clin Invest. 1989 Feb;83(2):430–436. doi: 10.1172/JCI113901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chandwani S., Greco M. A., Mittal K., Antoine C., Krasinski K., Borkowsky W. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis. 1991 May;163(5):1134–1138. doi: 10.1093/infdis/163.5.1134. [DOI] [PubMed] [Google Scholar]
  3. Chen H. L., Yang Y. P., Hu X. L., Yelavarthi K. K., Fishback J. L., Hunt J. S. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991 Aug;139(2):327–335. [PMC free article] [PubMed] [Google Scholar]
  4. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991 Jul 22;285(2):199–212. doi: 10.1016/0014-5793(91)80803-b. [DOI] [PubMed] [Google Scholar]
  5. Jauniaux E., Nessmann C., Imbert M. C., Meuris S., Puissant F., Hustin J. Morphological aspects of the placenta in HIV pregnancies. Placenta. 1988 Nov-Dec;9(6):633–642. doi: 10.1016/0143-4004(88)90007-0. [DOI] [PubMed] [Google Scholar]
  6. Kameda T., Matsuzaki N., Sawai K., Okada T., Saji F., Matsuda T., Hirano T., Kishimoto T., Tanizawa O. Production of interleukin-6 by normal human trophoblast. Placenta. 1990 May-Jun;11(3):205–213. doi: 10.1016/s0143-4004(05)80266-8. [DOI] [PubMed] [Google Scholar]
  7. Li Y., Matsuzaki N., Masuhiro K., Kameda T., Taniguchi T., Saji F., Yone K., Tanizawa O. Trophoblast-derived tumor necrosis factor-alpha induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor-dependent system in the normal human trophoblasts. J Clin Endocrinol Metab. 1992 Jan;74(1):184–191. doi: 10.1210/jcem.74.1.1727819. [DOI] [PubMed] [Google Scholar]
  8. Oliveira L. H., Fonseca M. E., De Bonis M. Placental phagocytic cells infected with herpes simplex type 2 and echovirus type 19: virological and ultrastructural aspects. Placenta. 1992 Sep-Oct;13(5):405–416. doi: 10.1016/0143-4004(92)90048-x. [DOI] [PubMed] [Google Scholar]
  9. Rachmilewitz J., Gonik B., Goshen R., Ariel I., Schneider T., Eldar-Geva T., de Groot N., Hochberg A. Intermediate cells during cytotrophoblast differentiation in vitro. Cell Growth Differ. 1993 May;4(5):395–402. [PubMed] [Google Scholar]
  10. Ringler G. E., Strauss J. F., 3rd In vitro systems for the study of human placental endocrine function. Endocr Rev. 1990 Feb;11(1):105–123. doi: 10.1210/edrv-11-1-105. [DOI] [PubMed] [Google Scholar]
  11. Romero R., Manogue K. R., Mitchell M. D., Wu Y. K., Oyarzun E., Hobbins J. C., Cerami A. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol. 1989 Aug;161(2):336–341. doi: 10.1016/0002-9378(89)90515-2. [DOI] [PubMed] [Google Scholar]
  12. Taniguchi T., Matsuzaki N., Kameda T., Shimoya K., Jo T., Saji F., Tanizawa O. The enhanced production of placental interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol. 1991 Jul;165(1):131–137. doi: 10.1016/0002-9378(91)90241-i. [DOI] [PubMed] [Google Scholar]
  13. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253–278. doi: 10.1146/annurev.iy.08.040190.001345. [DOI] [PubMed] [Google Scholar]
  14. Wegmann T. G., Guilbert L. J. Immune signalling at the maternal-fetal interface and trophoblast differentiation. Dev Comp Immunol. 1992 Nov-Dec;16(6):425–430. doi: 10.1016/0145-305x(92)90026-9. [DOI] [PubMed] [Google Scholar]
  15. Yang Y., Yelavarthi K. K., Chen H. L., Pace J. L., Terranova P. F., Hunt J. S. Molecular, biochemical, and functional characteristics of tumor necrosis factor-alpha produced by human placental cytotrophoblastic cells. J Immunol. 1993 Jun 15;150(12):5614–5624. [PubMed] [Google Scholar]
  16. Yelavarthi K. K., Hunt J. S. Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas. Am J Pathol. 1993 Oct;143(4):1131–1141. [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES